CL2020002644A1 - Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de un extracto de hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio (divisional de la solicitud 03354-2018) - Google Patents

Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de un extracto de hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio (divisional de la solicitud 03354-2018)

Info

Publication number
CL2020002644A1
CL2020002644A1 CL2020002644A CL2020002644A CL2020002644A1 CL 2020002644 A1 CL2020002644 A1 CL 2020002644A1 CL 2020002644 A CL2020002644 A CL 2020002644A CL 2020002644 A CL2020002644 A CL 2020002644A CL 2020002644 A1 CL2020002644 A1 CL 2020002644A1
Authority
CL
Chile
Prior art keywords
aspartate
skin
genes responsible
general functions
extract
Prior art date
Application number
CL2020002644A
Other languages
English (en)
Inventor
Savietto Joice Panzarin
Daniela Zimbardi
Fabiana Paes
Romeu Clarissa Capelas
Oliveira Reis Eduardo Alexandre De
D'annolfo Kassandra Tadini
Moncayo Priscila Carollo
De Oliveira Ricardo Augusto Santos
Simone Emidio
De Moura Soraya Baione
Original Assignee
Natura Cosmeticos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102016011816-6A external-priority patent/BR102016011816A2/pt
Priority claimed from BR102016011821-2A external-priority patent/BR102016011821A2/pt
Priority claimed from BR102016011807-7A external-priority patent/BR102016011807A2/pt
Priority claimed from BR102016011810-7A external-priority patent/BR102016011810A2/pt
Priority claimed from BR102016022683-0A external-priority patent/BR102016022683A2/pt
Priority claimed from BR102016022682-1A external-priority patent/BR102016022682A2/pt
Priority claimed from BR102016022679-1A external-priority patent/BR102016022679A2/pt
Priority claimed from BR102016022681-3A external-priority patent/BR102016022681A2/pt
Application filed by Natura Cosmeticos Sa filed Critical Natura Cosmeticos Sa
Publication of CL2020002644A1 publication Critical patent/CL2020002644A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a composiciones para modular genes responsables de las funciones generales de la piel que comprende la combinación de un extracto de Hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio y al menos un vehículo cosméticamente aceptable, así como a un método para modular la expresión de los genes responsables de las funciones generales de la piel, y uso del extracto vegetal en la preparación de una composición para modular genes responsables de las funciones generales de la piel.
CL2020002644A 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de un extracto de hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio (divisional de la solicitud 03354-2018) CL2020002644A1 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
BR102016011816-6A BR102016011816A2 (pt) 2016-05-24 2016-05-24 Composition for the modulation of genes responsible for general skin functions, method for modulating expression of genes responsible for general skin functions and use of cases sylvestris, schinus terebinthifolius and paeonia albiflora
BR102016011821-2A BR102016011821A2 (pt) 2016-05-24 2016-05-24 Composition for the modulation of genes responsible for general skin functions, method for modulating expression of genes responsible for general skin functions and use of ceramidas de maracujá and cichorium intybus
BR102016011807-7A BR102016011807A2 (pt) 2016-05-24 2016-05-24 Composition for modulation of genes responsible for general skin functions, method for modulating expression of genes responsible for general skin functions and use of camellia sinensis and espilantol
BR102016011810-7A BR102016011810A2 (pt) 2016-05-24 2016-05-24 Composition for the modulation of genes responsible for general skin functions, method for modulating expression of genes responsible for general skin functions and use of jatobá xyloglucan and a sodium cocoil amino acids and sarcosin and potassium aspartate and magnesium aspartate mix
BR102016022683-0A BR102016022683A2 (pt) 2016-09-29 2016-09-29 Composição para a modulação de genes responsáveis pelas funções gerais da pele, método para a modulação da expressão de genes responsáveis pelas funções gerais da pele e uso de spilol e ácido hialurônico
BR102016022682-1A BR102016022682A2 (pt) 2016-09-29 2016-09-29 Composição para a modulação de genes responsáveis pelas funções gerais da pele, método para a modulação da expressão de genes responsáveis pelas funções gerais da pele e uso de casearia sylvestris, schinus terebinthfolius e ácido hialurônico
BR102016022679-1A BR102016022679A2 (pt) 2016-09-29 2016-09-29 Composição para a modulação de genes responsáveis pelas funções gerais da pele, método para a modulação da expressão de genes responsáveis pelas funções gerais da pele e uso de schinus terebinthfolius e cafeína
BR102016022681-3A BR102016022681A2 (pt) 2016-09-29 2016-09-29 Composição para a modulação de genes responsáveis pelas funções gerais da pele, método para a modulação da expressão de genes responsáveis pelas funções gerais da pele e uso de hymenaea courbaril, paeonia albiflora, secale cereale e avena sativa

Publications (1)

Publication Number Publication Date
CL2020002644A1 true CL2020002644A1 (es) 2020-12-18

Family

ID=60411020

Family Applications (8)

Application Number Title Priority Date Filing Date
CL2018003354A CL2018003354A1 (es) 2016-05-24 2018-11-23 Composición para modular genes responsables de las funciones generales de la piel, método para modular la expresión de genes responsables de las funciones generales de la piel y uso de un extracto vegetal
CL2020002646A CL2020002646A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
CL2020002641A CL2020002641A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende un extracto vegetal de cichorium intybus y ceramidas de pasionaria (divisional de la solicitud 03354-2018)
CL2020002642A CL2020002642A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal de schinus terebinthifolius y cafeína (divisional de la solicitud 03354-2018)
CL2020002647A CL2020002647A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de extracto de acmella oleracea y ácido hialurónico (divisional de la solicitud 03354-2018)
CL2020002644A CL2020002644A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de un extracto de hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio (divisional de la solicitud 03354-2018)
CL2020002643A CL2020002643A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de hymenaea courbaril, paeonia albiflora, secale cereale y avena sativa (divisional de la solicitud 03354-2018)
CL2020002639A CL2020002639A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado del grupo que consiste de extractos de casearia sylvestris, schinus terebinthifolius y paeonia albiflora (divisional de la solicitud 03354-2018)

Family Applications Before (5)

Application Number Title Priority Date Filing Date
CL2018003354A CL2018003354A1 (es) 2016-05-24 2018-11-23 Composición para modular genes responsables de las funciones generales de la piel, método para modular la expresión de genes responsables de las funciones generales de la piel y uso de un extracto vegetal
CL2020002646A CL2020002646A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
CL2020002641A CL2020002641A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende un extracto vegetal de cichorium intybus y ceramidas de pasionaria (divisional de la solicitud 03354-2018)
CL2020002642A CL2020002642A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal de schinus terebinthifolius y cafeína (divisional de la solicitud 03354-2018)
CL2020002647A CL2020002647A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de extracto de acmella oleracea y ácido hialurónico (divisional de la solicitud 03354-2018)

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2020002643A CL2020002643A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de hymenaea courbaril, paeonia albiflora, secale cereale y avena sativa (divisional de la solicitud 03354-2018)
CL2020002639A CL2020002639A1 (es) 2016-05-24 2020-10-13 Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado del grupo que consiste de extractos de casearia sylvestris, schinus terebinthifolius y paeonia albiflora (divisional de la solicitud 03354-2018)

Country Status (5)

Country Link
US (1) US20200315950A1 (es)
BR (1) BR112018074219A2 (es)
CL (8) CL2018003354A1 (es)
MX (6) MX2018014431A (es)
WO (1) WO2017201597A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102017016427A2 (pt) * 2017-07-31 2019-03-26 Natura Cosméticos S.A. Método para avaliar hidratação bioativa de um ingrediente ou mistura de ingredientes, composições cosméticas para a modulação de genes responsáveis pela hidratação bioativa da pele e método para a modulação da expressão de genes responsáveis pela hidratação bioativa da pele
WO2021119664A1 (en) 2019-12-10 2021-06-17 Mary Kay Inc. Herbal cosmetic composition for treating skin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626469B1 (fr) * 1988-01-29 1990-07-20 Diot Michel Nouvelles preparations cosmetiques contenant un extrait des parties aeriennes de cichorium intybus l
JP2001322940A (ja) * 2000-05-12 2001-11-20 Kao Corp カテプシンｄ産生促進剤
JP2003055190A (ja) * 2001-08-07 2003-02-26 Koei Kogyo Kk コラゲナーゼ阻害剤及び抗老化用化粧料
FR3010313A1 (fr) * 2013-09-09 2015-03-13 Natura Cosmeticos Sa Composition comprenant un extrait de guacatonga et un extrait d'aroeira, son utilisation et methode pour empecher et/ou traiter les signes causes par le vieillissement de la peau

Also Published As

Publication number Publication date
CL2020002646A1 (es) 2020-12-18
CL2020002641A1 (es) 2020-12-18
MX2021003952A (es) 2022-07-19
BR112018074219A2 (pt) 2019-03-06
CL2020002642A1 (es) 2020-12-18
MX2021003950A (es) 2021-05-27
CL2020002639A1 (es) 2020-12-18
CL2020002647A1 (es) 2020-12-18
MX2021003953A (es) 2021-05-27
US20200315950A1 (en) 2020-10-08
WO2017201597A1 (pt) 2017-11-30
CL2018003354A1 (es) 2019-08-23
MX2021003959A (es) 2021-05-27
MX2021003951A (es) 2021-05-27
CL2020002643A1 (es) 2020-12-18
MX2018014431A (es) 2019-03-28

Similar Documents

Publication Publication Date Title
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
CO2021007993A2 (es) Compuestos de 2‐formil‐3‐hidroxifeniloximetilo capaces de modular la hemoglobina
CL2020000422A1 (es) Composiciones de glp-1 y sus usos.
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
CL2020002644A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende la combinación de un extracto de hymenaea courbaril y una mezcla de cocoilaminoácidos de sodio y sarcosina y aspartato de potasio y aspartato de magnesio (divisional de la solicitud 03354-2018)
BR112017011476A2 (pt) composição baseada em aminoácidos para recuperação de fibroelastina em tecidos conjuntivos dérmicos e uso
CL2018001210A1 (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico.
UY33634A (es) ?combinaciones sinérgicas de triazoles, estrobirulinas y benzimidazoles, usos, formulaciones, procedimientos de producción y aplicaciones utilizando las mismas?.
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
MX2020004675A (es) Formulaciones de alcohol de seda.
AR107195A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales
CL2010000743A1 (es) Compuestos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CL2019003801A1 (es) Nuevas formulaciones orales de belinostato.
UY38195A (es) Composiciones de placebo de cannabis, vehículos de administración y un método para emparejar el color/neutralización de productos de cannabis
CL2018000753A1 (es) Gel hidrófobo basado en vitamina e libre de productos de silicona para aplicación tópica
GT201400115A (es) Combinación farmacéutica antineurítica y composición
AR044623A1 (es) Grasa vegetal modificada
DOP2020000131A (es) Combinaciones de lipidos
AR116986A1 (es) Composición cosmética, método para la producción de aceite y/o manteca de astrocaryum vulgare, uso de la composición cosmética y método para la producción y/o protección contra la degradación del ácido hialurónico en la piel
AR123580A1 (es) Composiciones alimenticias y sus aplicaciones
CL2021001637A1 (es) Composiciones alimenticia y aditiva, así como usos de la lignina y de la composición aditiva.
ECSP21075150A (es) Complejo cosmético y usos del mismo
AR116715A1 (es) Composición de fragancias, métodos para reducir fatiga y mejorar función ejecutiva del cerebro administrando dicha composición, uso de dicha composición, producto cosmético y vela que contiene dicha composición; y dispositivo pulverizador de dicha composición